Mylan's most recent trend suggests a bullish bias. One trading opportunity on Mylan is a Bull Put Spread using a strike $55.00 short put and a strike $50.00 long put offers a potential 17.37% return on risk over the next 29 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $55.00 by expiration. The full premium credit of $0.74 would be kept by the premium seller. The risk of $4.26 would be incurred if the stock dropped below the $50.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Mylan is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Mylan is bullish.
The RSI indicator is at 64.07 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Mylan
Mylan (MYL) Stock: Moving Average Crossover Alert
Wed, 19 Nov 2014 12:49:18 GMT
Munich Raid, Credit Suisse Waiver, Summit Tax Talk: Compliance
Mon, 17 Nov 2014 05:01:01 GMT
EpiPen4Schools® Program Enhances Support of National Movement to Improve Anaphylaxis Preparedness and Access to Emergency Treatment in Schools
Fri, 14 Nov 2014 11:42:22 GMT
noodls – Survey Findings Reveal Incidence of First-Time Reactions in School Setting PITTSBURGH , Oct. 27, 2014 /PRNewswire/ — Mylan Specialty, the fully integrated specialty pharmaceutical business of Mylan Inc. …
Mylan Launches Generic Viramune XR®
Fri, 14 Nov 2014 11:42:21 GMT
noodls – PITTSBURGH , Oct. 30, 2014 /PRNewswire/ — Mylan Inc. (Nasdaq: MYL) today announced the U.S. launch of its Nevirapine Extended-release tablets, 400 mg, which is the generic version of Boehringer Ingelheim's …
Mylan Third Quarter 2014 Adjusted Diluted EPS Increases 41% to $1.16
Fri, 14 Nov 2014 11:42:20 GMT
noodls – 2014 Adjusted Diluted EPS Guidance Range Increases to $3.54 to $3.60 PITTSBURGH , Oct. 30, 2014 /PRNewswire/ — Mylan Inc. (Nasdaq: MYL) today announced its financial results for the three and nine months …
Also on Market Tamer…
Follow Us on Facebook